These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 32800938

  • 1. Osmotic pump tablets with solid dispersions synergized by hydrophilic polymers and mesoporous silica improve in vitro/in vivo performance of cilostazol.
    Zhang S, Sun Y, Zhou L, Jiang Z, Yang X, Feng Y.
    Int J Pharm; 2020 Oct 15; 588():119759. PubMed ID: 32800938
    [Abstract] [Full Text] [Related]

  • 2. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
    Miao X, Sun C, Jiang T, Zheng L, Wang T, Wang S.
    J Pharm Pharm Sci; 2011 Oct 15; 14(2):196-214. PubMed ID: 21733409
    [Abstract] [Full Text] [Related]

  • 3. Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.
    Yanfei M, Guoguang C, Lili R, Pingkai O.
    Drug Dev Ind Pharm; 2015 Oct 15; 41(8):1353-62. PubMed ID: 25138348
    [Abstract] [Full Text] [Related]

  • 4. Preparation and Characterization of Furosemide Solid Dispersion with Enhanced Solubility and Bioavailability.
    Zhang F, Mao J, Tian G, Jiang H, Jin Q.
    AAPS PharmSciTech; 2022 Jan 31; 23(1):65. PubMed ID: 35102461
    [Abstract] [Full Text] [Related]

  • 5. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
    Zhao Z, Gao Y, Wu C, Hao Y, Zhao Y, Xu J.
    Drug Dev Ind Pharm; 2016 Jan 31; 42(2):199-208. PubMed ID: 26114553
    [Abstract] [Full Text] [Related]

  • 6. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast.
    Madan JR, Pawar AR, Patil RB, Awasthi R, Dua K.
    Polim Med; 2018 Jan 31; 48(1):17-24. PubMed ID: 30657654
    [Abstract] [Full Text] [Related]

  • 7. Increased dissolution rate and oral bioavailability of hydrophobic drug glyburide tablets produced using supercritical CO₂ silica dispersion technology.
    Guan J, Han J, Zhang D, Chu C, Liu H, Sun J, He Z, Zhang T.
    Eur J Pharm Biopharm; 2014 Apr 31; 86(3):376-82. PubMed ID: 24184803
    [Abstract] [Full Text] [Related]

  • 8. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
    Wang Y, Sun L, Jiang T, Zhang J, Zhang C, Sun C, Deng Y, Sun J, Wang S.
    Drug Dev Ind Pharm; 2014 Jun 31; 40(6):819-28. PubMed ID: 23594300
    [Abstract] [Full Text] [Related]

  • 9. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.
    Yang M, He S, Fan Y, Wang Y, Ge Z, Shan L, Gong W, Huang X, Tong Y, Gao C.
    Int J Pharm; 2014 Nov 20; 475(1-2):97-109. PubMed ID: 25171976
    [Abstract] [Full Text] [Related]

  • 10. Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure.
    Wu C, Zhao Z, Zhao Y, Hao Y, Liu Y, Liu C.
    Int J Pharm; 2014 Nov 20; 475(1-2):298-305. PubMed ID: 25148731
    [Abstract] [Full Text] [Related]

  • 11. Comparison of three different types of cilostazol-loaded solid dispersion: Physicochemical characterization and pharmacokinetics in rats.
    Mustapha O, Kim KS, Shafique S, Kim DS, Jin SG, Seo YG, Youn YS, Oh KT, Yong CS, Kim JO, Choi HG.
    Colloids Surf B Biointerfaces; 2017 Jun 01; 154():89-95. PubMed ID: 28324691
    [Abstract] [Full Text] [Related]

  • 12. Development of an oral push-pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles.
    Zhao Z, Wu C, Zhao Y, Hao Y, Liu Y, Zhao W.
    Int J Nanomedicine; 2015 Jun 01; 10():1691-701. PubMed ID: 25784799
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development and optimization of osmotically controlled drug delivery system for poorly aqueous soluble diacerein to improve its bioavailability.
    Mohamed MI, Al-Mahallawi AM, Awadalla SM.
    Drug Dev Ind Pharm; 2020 May 01; 46(5):814-825. PubMed ID: 32306779
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enteric and hydrophilic polymers enhance dissolution and absorption of poorly soluble acidic drugs based on micro-environmental pH-modifying solid dispersion.
    Zhang S, Xu X, Sun W, Zhang Z, Pan B, Hu Q.
    Eur J Pharm Sci; 2022 Jan 01; 168():106074. PubMed ID: 34798261
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dissolution and oral bioavailability enhancement of praziquantel by solid dispersions.
    Liu Y, Wang T, Ding W, Dong C, Wang X, Chen J, Li Y.
    Drug Deliv Transl Res; 2018 Jun 01; 8(3):580-590. PubMed ID: 29450806
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.